Resolution of a neurotrophic keratopathy associated hypopyon with cenegermin

Purpose: We present a novel case of a neurotrophic keratopathy associated inflammatory hypopyon that resolved after initiation of therapy with cenegermin (Oxervate; Dompe, Milan, Italy), a recombinant human nerve growth factor (rhNGF). This finding illustrates the potential of cenegermin in advanced...

Full description

Bibliographic Details
Main Authors: Nick Zambino, Zeba A. Syed
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993621001225

Similar Items